Related Experiment Videos
Prostate cancer update
1University of California at San Francisco Comprehensive Cancer Center, San Francisco, California 94115, USA. brini@medicine.utsf.edu
Abstract:
Recent advances in prostate cancer have focused on treatment strategies in patients with biochemical relapse and novel methods of androgen deprivation therapy such as intermittent therapy, the role of bisphosphonates, and immunotherapeutic approaches. Continued investigation into the mechanism of androgen independence and effective treatments for hormone-refractory disease are described. This article reviews the major advances in prostate cancer published between November 1, 2000, and October 31, 2001.
Insights
This review covers prostate cancer advances from 2000-2001, focusing on biochemical relapse treatments, new androgen deprivation therapy methods, bisphosphonates, and immunotherapy for hormone-refractory disease.
Area of Science:
- Oncology
- Urology
Background:
- Prostate cancer treatment is evolving.
- Focus is shifting towards managing relapse and improving therapy efficacy.
Purpose of the Study:
- To review significant advancements in prostate cancer research.
- To cover developments between November 2000 and October 2001.
Main Methods:
- Literature review of published studies.
- Analysis of recent findings in prostate cancer therapy.
Main Results:
- Exploration of novel androgen deprivation therapy (ADT) strategies.
- Investigation into bisphosphonates and immunotherapy.
- Continued research into androgen independence and hormone-refractory prostate cancer.
Conclusions:
- Significant progress has been made in understanding and treating advanced prostate cancer.
- New therapeutic avenues are emerging for patients with biochemical relapse and hormone-refractory disease.